Media Release

Penzberg, Germany, 06 November 2012

Roche launches new Light Cycler 96 System enabling broad application of its high-performance PCR technology in academic research

Light Cycler 96
Light Cycler 96

System debuts at Conference of American Society of Human Genetics in San Francisco

Today Roche announced the global launch of its new LightCycler 96 System, which completes its portfolio of Real Time PCR instruments for life science research. The system’s unique combination of innovative features will be premiered at the Annual Meeting of the American Society of Human Genetics (ASHG), which will be taking place in San Francisco from November 6 – 10.

The Light Cycler 96 System offers highly accurate, reproducible and fast data generation for researchers working in a wide range of fields such as gene expression and genetic variation research. The system permits flexible adaptation of workflows to specific assay formats and throughput needs. It also provides guided navigation and intuitive software for first-time users as well as a full set of analytical capabilities for experienced operators. The data generated by the system can be analyzed directly or remotely for translation to publication-ready results in line with MIQE1 guidelines.

“The LightCycler 96 System reflects more than a decade of Roche expertise and continuous innovation in PCR technology and brings the high quality and reliability of our PCR systems within the reach of every researcher,” said Gerd Haberhausen, Head of qPCR and Sample Preparation Systems. “The instrument’s new silver block ensures outstanding temperature homogeneity and therefore enables a maximum of data consistency and accuracy. In addition, the new Light Cycler 96 puts the user right at the center by providing highly intuitive, user-friendly software and interfaces.”  

Thanks to its innovative glass fiber optics, the Light Cycler 96 System offers equal and simultaneous data capture from all 96 wells, while avoiding the signal variations commonly seen in systems that use optical scanning. It is also calibration- free as it does not require a passive reference dye.

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 42.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

LIGHTCYCLER is a trademark of Roche
All other product names and trademarks are the property of their respective owners.

1) MIQE: Minimum information required for publication of quantification experiments